This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Health product recall

Cefazolin for injection - 1gm and 10gm PWS

Starting date:
March 14, 2013
Posting date:
April 2, 2013
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-26487

Recalled Products

  1. Cefazolin for injection - 10 gm PWS
  2. Cefazolin for injection - 1 gm PWS

Reason

Teva Canada initiated the voluntary recall due to the presence of particulate matter in the product upon reconstitution.

Depth of distribution

Recall to retail level: Distribution in Canada.

Affected products

A. Cefazolin for injection - 10 gm PWS

DIN, NPN, DIN-HIM
DIN 02108135
Dosage form
  • Powder for Solution
Strength
  • 10 g / vial
Lot or serial number
  • 352276
  • 352277
Companies
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Novopharm Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA

B. Cefazolin for injection - 1 gm PWS

DIN, NPN, DIN-HIM
DIN 02108127
Dosage form
  • Powder for Solution
Strength
  • 1 g / vial
Lot or serial number
  • 360301
  • 360302
Companies
Recalling Firm
Teva - Novopharm Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Novopharm Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA